-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
June 01, 2012 - PowerPoint Presentation
Challenges in and Principles for Conducting Systematic Reviews of Genetic Tests Used as
Predictive Indicators
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Challenges in and Principles for Conducting…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
June 01, 2012 - PowerPoint Presentation
Challenges in and Principles for Conducting Systematic Reviews of Genetic Tests Used as
Predictive Indicators
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Challenges in and Principles for Conducting…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-272-genitourinary-syndrome-executive-summary.pdf
July 01, 2024 - substantial literature base, especially for vaginal estrogen
therapies that are not FDA-approved for any indication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
August 05, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: August 05, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness and Safety of
Analgesics for Osteoarthritis – An Update to the 2006 Report
I. Background and Objectives f…
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
December 01, 2015 - indicated that
ES-4
off-label use of topiramate did not have potential for high impact for this indication … Prevention of
Hazardous Alcohol Use
Unmet need: Hazardous alcohol use is a composite substance abuse indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_surveillance.pdf
October 29, 2012 - The identification of an updating signal (qualitative or
quantitative) would be an indication that the … The identification of an updating signal (qualitative or quantitative) would
be an indication that the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
September 01, 2009 - Food and Drug Administration for
this indication and tibolone is not.
-
effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
October 01, 2007 - ORIGINAL ARTICLE
Developing Indicators of Inpatient Adverse Drug Events
Through Nonlinear Analysis Using Administrative Data
Jonathan R. Nebeker, MS, MD,*†‡§ Paul R. Yarnold, PhD,¶ Robert C. Soltysik, MS,�
Brian C. Sauer, PhD,†‡ Shannon A. Sims, MD, MS,** Matthew H. Samore, MD,†‡§**
Randall W. Rupper, MD, MPH,*†‡ Ka…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol-amendment.pdf
December 28, 2023 - Updating the Measurement Criteria for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR)
Version 5 4/18/2019 1
Evidence-based Practice Center
Technical Brief Protocol
Project Title: Updating the Measurement Criteria for AHRQ’s
National Healthcare Quality and Disparities Report (NHQDR)
Init…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - our protocol (for
instance, one person suggested including insomnia, which is already an included indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
November 28, 2023 - Evaluation of Dietary Protein Intake Requirements
Evidence-Based Practice Center Systematic Review Protocol
Project Title: Evaluation of Dietary Protein Intake Requirements
Publication Date: June 2, 2023
Amendment Date(s): November 17, 2023, November 28, 2023
(Amendments Details–see Section VI)
I. B…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - In
addition, the GLP-1 agonist exenatide was approved for the indication of monotherapy, in
addition
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
January 01, 2014 - We recommend this sentence be revised to include
FDA‐approved indication in this statement: “One SRT … We note that some of this information about the
FDA‐approved indication appears in next paragraph, but … Lumizyme is considered by the FDA to be a
distinct product and has a different FDA-approved indication … We do note,
however, that the indication for Myozyme is correctly listed
under the column “Clinical … Indication and Outcomes
Measured in the FDA-Approved Prescribing Information.
3.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-mobile-apps-disposition-of-comments.pdf
May 20, 2022 - tablet – thus appearing externally to be the same – each product
type has a very different purpose, indication … helps ensure that the DTx therapy is being used by the
right patient at the right time for the right indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol.pdf
September 06, 2023 - EHC Protocol: Updating the Measurement Criteria for AHRQ's National Healthcare Quality and Disparities Report
Evidence-based Practice Center Technical Brief Protocol
Project Title: Updating the Measurement Criteria for AHRQ’s National
Healthcare Quality and Disparities Report (NHQDR)
I. Background and Objectives…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
May 01, 2021 - CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update
Comparative Effectiveness Review
Number 244
Safety of Vaccines Used for Routine
Immunization in the United States: An Update
Evidence Summary
Main Points
Background and Purpose
Considere…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-disposition-comments.pdf
May 22, 2023 - Additionally, they have the even
greater methodological challenges of selection
bias and confounding by indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fetal-surgery_disposition-comments.pdf
July 05, 2011 - This minimally-invasive
approach has essentially removed the indication for
open fetal surgery for … The majority of CPAMs
however do not have an indication for
prenatal treatment as the outcomes are … circulation”
Peer Reviewer
#10
Results hydrops (not impairment of fetal lung growth) is the
indication … This minimally-invasive
approach has essentially removed the indication for
open fetal surgery for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
November 20, 2014 - and chose the
previous 5 years to manage the scope since
we were looking at studies regardless of
indication … Therefore, we limit our comments to those topics that are related to
this type of imaging and this indication … For
each indication, the guidelines rank specific value and
appropriateness. … Dose notifications are designed
to provide a clear indication to health care providers when the
parameters
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
September 06, 2023 - Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR)
Evidence-based Practice Center Technical Brief Protocol
Project Title: Updating the Framework for AHRQ’s National Healthcare
Quality and Disparities Report (NHQDR)
I. Background and Objectives for the Technical…